KMDA
NASDAQ · Biotechnology
Kamada Ltd
$8.25
+0.05 (+0.61%)
Open$8.23
Previous Close$8.20
Day High$8.26
Day Low$8.15
52W High$9.08
52W Low$5.54
Volume—
Avg Volume74.4K
Market Cap499.52M
P/E Ratio24.43
EPS$0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+251.8% upside
Current
$8.25
$8.25
Target
$29.02
$29.02
$25.25
$29.02 avg
$47.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 158.02M | 136.44M | 67.17M |
| Net Income | 14.20M | 11.03M | -1,989,318 |
| Profit Margin | 9.0% | 8.5% | -3.0% |
| EBITDA | 13.58M | 11.14M | -2,803,887 |
| Free Cash Flow | — | — | -2,727,774 |
| Rev Growth | +15.8% | +15.8% | +14.3% |
| Debt/Equity | 0.04 | 0.04 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |